chrX-139562066-A-C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_000133.4(F9):​c.1381A>C​(p.Thr461Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000277 in 1,207,222 control chromosomes in the GnomAD database, including 3 homozygotes. There are 99 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T461A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 1 hom., 43 hem., cov: 23)
Exomes 𝑓: 0.00018 ( 2 hom. 56 hem. )

Consequence

F9
NM_000133.4 missense

Scores

7
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.15

Publications

4 publications found
Variant links:
Genes affected
F9 (HGNC:3551): (coagulation factor IX) This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Sep 2015]
F9 Gene-Disease associations (from GenCC):
  • hemophilia B
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • mild hemophilia B
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • moderately severe hemophilia B
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • severe hemophilia B
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of hemophilia B in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • thrombophilia, X-linked, due to factor 9 defect
    Inheritance: XL Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 162 curated pathogenic missense variants (we use a threshold of 10). The gene has 21 curated benign missense variants. Gene score misZ: 2.1809 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to hemophilia B, symptomatic form of hemophilia B in female carriers, thrombophilia, X-linked, due to factor 9 defect, mild hemophilia B, severe hemophilia B, moderately severe hemophilia B.
BP4
Computational evidence support a benign effect (MetaRNN=0.0071655214).
BP6
Variant X-139562066-A-C is Benign according to our data. Variant chrX-139562066-A-C is described in ClinVar as Benign. ClinVar VariationId is 368004.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00128 (143/111949) while in subpopulation AFR AF = 0.00416 (128/30806). AF 95% confidence interval is 0.00357. There are 1 homozygotes in GnomAd4. There are 43 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 43 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F9NM_000133.4 linkc.1381A>C p.Thr461Pro missense_variant Exon 8 of 8 ENST00000218099.7 NP_000124.1 P00740-1
F9NM_001313913.2 linkc.1267A>C p.Thr423Pro missense_variant Exon 7 of 7 NP_001300842.1 P00740-2
F9XM_005262397.5 linkc.1252A>C p.Thr418Pro missense_variant Exon 7 of 7 XP_005262454.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F9ENST00000218099.7 linkc.1381A>C p.Thr461Pro missense_variant Exon 8 of 8 1 NM_000133.4 ENSP00000218099.2 P00740-1
F9ENST00000394090.2 linkc.1267A>C p.Thr423Pro missense_variant Exon 7 of 7 1 ENSP00000377650.2 P00740-2
F9ENST00000643157.1 linkn.1723+325A>C intron_variant Intron 6 of 6

Frequencies

GnomAD3 genomes
AF:
0.00125
AC:
140
AN:
111895
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00407
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00104
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00200
GnomAD2 exomes
AF:
0.000374
AC:
68
AN:
181976
AF XY:
0.000238
show subpopulations
Gnomad AFR exome
AF:
0.00467
Gnomad AMR exome
AF:
0.000256
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000723
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000223
GnomAD4 exome
AF:
0.000175
AC:
192
AN:
1095273
Hom.:
2
Cov.:
29
AF XY:
0.000155
AC XY:
56
AN XY:
360779
show subpopulations
African (AFR)
AF:
0.00547
AC:
144
AN:
26344
American (AMR)
AF:
0.000369
AC:
13
AN:
35185
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19371
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30195
South Asian (SAS)
AF:
0.0000740
AC:
4
AN:
54026
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40436
Middle Eastern (MID)
AF:
0.000727
AC:
3
AN:
4127
European-Non Finnish (NFE)
AF:
0.0000107
AC:
9
AN:
839572
Other (OTH)
AF:
0.000413
AC:
19
AN:
46017
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00128
AC:
143
AN:
111949
Hom.:
1
Cov.:
23
AF XY:
0.00126
AC XY:
43
AN XY:
34125
show subpopulations
African (AFR)
AF:
0.00416
AC:
128
AN:
30806
American (AMR)
AF:
0.00104
AC:
11
AN:
10591
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3553
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2667
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6082
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53179
Other (OTH)
AF:
0.00197
AC:
3
AN:
1520
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000379
Hom.:
25
Bravo
AF:
0.00139
ESP6500AA
AF:
0.00235
AC:
9
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000453
AC:
55

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary factor IX deficiency disease Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect Benign:1
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.50
T;.
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.68
T;T
MetaRNN
Benign
0.0072
T;T
MetaSVM
Uncertain
0.055
D
MutationAssessor
Benign
1.6
L;.
PhyloP100
2.2
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-1.5
N;N
REVEL
Uncertain
0.31
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.0070
D;D
Polyphen
1.0
D;.
Vest4
0.076
MVP
0.82
MPC
1.8
ClinPred
0.039
T
GERP RS
2.9
Varity_R
0.65
gMVP
0.94
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4149751; hg19: chrX-138644225; API